No Data
No Data
Zhejiang Anglikang Pharmaceutical (002940.SZ): Pregabalin capsules (75mg, 150mg) have obtained the Pharmaceutical registration certificate.
Zhejiang Anglikang Pharmaceutical (002940.SZ) issued an announcement stating that recently, the company received a notice from the National Medical Products Administration ("National Drug Administration...")
Anglikang Pharma Gets Registration Certificate for Levitra Cream
Zhejiang Anglikang Pharmaceutical (002940.SZ): Lidocaine dibucaine cream has obtained the Pharmaceutical registration certificate.
On January 8, Gelonghui announced that Zhejiang Anglikang Pharmaceutical Co., Ltd. recently received the Pharmaceutical Registration Certificate issued by the National Medical Products Administration for Ropivacaine and Bupivacaine Cream. Ropivacaine and Bupivacaine Cream is a compound preparation of Lidocaine and Prilocaine, which is an external local anesthetic analgesic used for local anesthesia of the skin in the following situations: needle puncture, such as catheter placement or blood sampling; superficial surgical procedures, such as mucous membranes of the genital area, before superficial surgical procedures or infiltration anesthesia, and cleaning/debridement of leg ulcers. According to relevant national policy regulations, this time the Pharmaceutical Registration Certificate was obtained.
Zhejiang Anglikang Pharmaceutical (002940.SZ): has cumulatively repurchased 1.40% of its shares.
Gelonghui, January 2nd丨Zhejiang Anglikang Pharmaceutical (002940.SZ) announced that as of December 31, 2024, the company has repurchased a total of 2,820,000 shares through a special repurchase securities account via centralized bidding, accounting for approximately 1.40% of the company's total share capital, with a highest Fill Price of 14.87 yuan/share, a lowest Fill Price of 13.38 yuan/share, and a total transaction amount of 40.3959 million yuan (excluding transaction fees).
Zhejiang Anglikang Pharmaceutical (002940.SZ): Compound alpha-keto acid tablets are intended to be selected for the national Pharmaceutical centralized procurement.
Zhejiang Anglikang Pharmaceutical (002940.SZ) announced that on December 12, 2024, the company participated in the national organized Pharmaceutical joint...
Zhejiang Anglikang Pharmaceutical (002940.SZ): Supplementary application for cephalosporin hydrochloride, a chemical raw material drug, has been approved.
Zhejiang Anglikang Pharmaceutical (002940.SZ) issued an announcement stating that recently, the company received a notice from the National Medical Products Administration ("National Drug Administration...")
The Market Doesn't Like What It Sees From Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s (SZSE:002940) Earnings Yet As Shares Tumble 28%